Welcome to the e-CCO Library!

DOP23: Single-cell RNA sequencing identifies an important role for class I histone-deacetylase enzymes in intestinal myofibroblasts from patients with Crohn’s Disease strictures
Year: 2021
Source: ECCO'21 Virtual
Authors: Lewis, A.(1);Pan-Castillo, B.(2);Berti, G.(2);Felice, C.(1);Gordon, H.(3);Gadhok, R.(3);Minicozzi, A.(4);Chinaleong , J.(5);Feakins, R.(6);Lindsay, J.(3);Silver, A.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP23: The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort
Year: 2024
Source: ECCO'24 Stockholm
Authors: Reenaers, Catherine
Created: Tuesday, 30 April 2024, 5:03 PM
DOP24 Patient-reported health-related quality-of-life outcomes with vedolizumab vs. adalimumab treatment of ulcerative colitis: Results of the VARSITY trial
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E.V. Loftus Jr1, S.W. Schreiber2, S. Danese3, L. Peyrin-Biroulet4, J.F. Colombel5, B.E. Sands5, S. Wang6, J. Chen7, R.A. Lirio8

Created: Thursday, 30 January 2020, 10:12 AM
DOP24: Crohn’s Disease fistula show skewed lymphoid/myeloid balance, altered myeloid cell profiles and high TNF-α expression
Year: 2021
Source: ECCO'21 Virtual
Authors: Beckerdrs., M.(1);de Krijger, M.(1);Bemelman, W.(2);de Jonge, W.(1);Buskens, C.(2);Wildenberg, M.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, Canada
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Canisius Fantodji
Created: Friday, 14 July 2023, 2:22 PM
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, Canada
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fantodji, C.(1)*;Rousseau, M.C.(1);Nicolau, B.(2);Madathil, S.(2);Benedetti, A.(3);Jantchou, P.(4);
Created: Friday, 14 July 2023, 10:43 AM
DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesis
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Bruce Weder
Created: Tuesday, 28 May 2019, 3:32 PM
Fibroblast, Fibrosis
Files: 1
DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Weder*1, W. T. Van Haaften2, K. Baebler1, G. Rogler3, G. Dijkstra4, P. H. Imenez Silva5, Y. Wang5, C. De Vallière3, C. Wagner5, I. Frey-Wagner3, K. Seuwen6, P. Ruiz3, M. Hausmann3

Created: Friday, 22 February 2019, 9:41 AM
DOP24: Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim analyses of the J-COMBAT trial
Year: 2022
Source: ECCO'22
Authors: WatanabeDirector of division- Assistan, K.(1);Hisamatsu, T.(2);Nakase, H.(3);Nagase, K.(1);Matsuura, M.(2);Aoyama, N.(4);Kobayashi, T.(5);Sakuraba, H.(6);Yokoyama, K.(7);Nishishita, M.(8);Esaki , M.(9);Hirai, F.(10);Nagahori, M.(11);Nanjo, S.(12);Omori, T.(13);Tanida, S.(14);Yokoyama, Y.(3);Moriya, K.(15);Maemoto, A.(16);Handa, O.(17);Ohmiya, N.(18);Shinzaki, S.(19);Kato, S.(20);Tanaka, H.(21);Uraoka, T.(22);Takatsu, N.(23);Suzuki, H.(24);Takahashi, K.(25);Umeno, J.(26);Mishima, Y.(27);Tsuchida, K.(28);Fujiya, M.(29);Hiraoka, S.(30);Yamamoto, S.(31);Saruta, M.(32);Nojima, M.(33);Andoh, A.(25);
Created: Friday, 11 February 2022, 3:52 PM
DOP25 Medication use and comorbidities among elderly when compared with younger patients with inflammatory bowel disease in the TARGET-IBD cohort
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Barnes1, J. Hanson2, M. Regueiro3, S. Saha4, B.E. Sands5, D. Rubin6, M. Dubinsky7, C. Siegel8, D. Gazis9, J. Crawford10, M. Long1

Created: Thursday, 30 January 2020, 10:12 AM
DOP25: Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative Colitis
Year: 2024
Source: ECCO'24 Stockholm
Authors: Mendieta Escalante, Erick Arturo
Created: Tuesday, 30 April 2024, 5:03 PM
DOP25: Association of Enterobacteriaceae with Crohn’s Disease subtypes during remission
Year: 2021
Source: ECCO'21 Virtual
Authors: Pisani, A.(1);Rausch, P.(2);Ellul, S.(3);Bang, C.(2);Tabone, T.(1);Marantidis Cordina, C.(4);Zahra, G.(5);Ellul, P.(1);Franke, A.(2)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP25: Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Wetwittayakhlang, P.(1);Albader, F.(2);Golovics, P.(1);Drügg Hahn, G.(1);Bessissow, T.(1); Bitton, A.(1); Afif, W.(1);Wild, G.(1);LakatosPhD, P.L.(1); Inflammatory bowel disease McGill University Health Centre
Created: Friday, 11 February 2022, 3:52 PM
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Erica Brenner
Created: Friday, 14 July 2023, 2:22 PM
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Brenner, E.(1)*;Zhang, X.(2);Long, M.(3);Dubinsky, M.(4);Kappelman, M.(2);
Created: Friday, 14 July 2023, 10:43 AM
DOP25: Medication use and comorbidities among elderly as compared to younger patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort
Year: 2020
Source: ECCO'20 Vienna
Authors: Bruce E Sands
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP25: Unraveling Vedolizumab mechanism of action in Ulcerative Colitis
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Marisol Veny
Created: Tuesday, 28 May 2019, 3:32 PM
Vedolizumab, Lymphocyte
Files: 1
DOP25: Unravelling vedolizumab mechanism of action in ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Veny*1, A. Garrido1, H. Bassolas-Molina1, M. C. Masamunt1, M. Esteller1, M. Arroyes1, A. M. Corraliza1, E. Tristán2, A. Fernández-Clotet1, I. Ordás1, E. Ricart1, M. Esteve2, J. Panés1, A. Salas1

Created: Friday, 22 February 2019, 9:41 AM